The House will soon vote on a Democrat bill that would cap the price of insulin, which is viewed by Republicans as a cynical ploy to boost Sen. Raphael Warnock’s (D-GA) re-election chances, according to Breitbart News.
The Affordable Insulin Now Act legislation, sponsored by Sen. Warnock and 34 other Senate Democrats, would cap the cost-sharing under private health insurance for a month’s supply of insulin at $35 or 25 percent of the plan’s negotiated price starting in 2023. The bill would also cap the cost of insulin under Medicare to $35 or 25 percent of the plan’s negotiated price.
Not one Republican has backed the bill. House Republican leadership contends that it would expand government control over Americans’ health care and result in less access to life-saving treatments.
“This legislation is a simplistic proposal to address a highly complex problem. We cannot afford half-hearted proposals based on unsound economics like this one for an issue that impacts so many,” said FreedomWorks President Adam Brandon.
A Republican aide told Breitbart News, “This is a cheap bumper sticker slogan to try to get Warnock elected, not a serious solution to a serious problem.”